Brexpiprazole for Bipolar Depression

Summary

Brexpiprazole for Bipolar Depression is a clinical trial^[1].

Key Facts

• Brexpiprazole for Bipolar Depression is in the country of United States^[2].
• Brexpiprazole for Bipolar Depression's instance of is recorded as clinical trial^[3].
• Brexpiprazole for Bipolar Depression's start time is recorded as +2017-03-01T00:00:00Z^[4].
• Brexpiprazole for Bipolar Depression's end time is recorded as +2018-03-15T00:00:00Z^[5].
• Brexpiprazole for Bipolar Depression's sponsor is recorded as University of Texas Southwestern Medical Center^[6].
• Brexpiprazole for Bipolar Depression's main subject is recorded as major depressive disorder^[7].
• Brexpiprazole for Bipolar Depression's main subject is recorded as bipolar disorder^[8].
• Brexpiprazole for Bipolar Depression's number of participants is recorded as {'unit': '1', 'amount': '+21'}^[9].
• Brexpiprazole for Bipolar Depression's title is recorded as Brexpiprazole for Bipolar Depression^[10].
• Brexpiprazole for Bipolar Depression's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[11].
• Brexpiprazole for Bipolar Depression's ClinicalTrials.gov ID is recorded as NCT03427892^[12].
• Brexpiprazole for Bipolar Depression's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}^[13].
• Brexpiprazole for Bipolar Depression's research intervention is recorded as brexpiprazole^[14].
• Brexpiprazole for Bipolar Depression's clinical trial phase is recorded as phase IV clinical trial^[15].
• Brexpiprazole for Bipolar Depression's research site is recorded as University of Texas Southwestern Medical Center^[16].
• Brexpiprazole for Bipolar Depression's study type is recorded as interventional study^[17].